Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey

[1]  Y. Itoyama,et al.  Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years , 2009, Multiple sclerosis.

[2]  F. Mihara,et al.  Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis , 2008, Multiple sclerosis.

[3]  F. Mihara,et al.  Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings , 2008, Journal of the Neurological Sciences.

[4]  F. Mihara,et al.  Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. , 2007, Brain : a journal of neurology.

[5]  K. Tanaka,et al.  Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions , 2007, Multiple sclerosis.

[6]  Y. Itoyama,et al.  Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features , 2007, Journal of Neurology.

[7]  J. Kira,et al.  Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity , 2006, Journal of Neuroimmunology.

[8]  F. Mihara,et al.  Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings , 2006, Journal of the Neurological Sciences.

[9]  Y. Itoyama,et al.  Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  K. Fujihara,et al.  OSMS is NMO, but not MS: proven clinically and pathologically , 2006, The Lancet Neurology.

[11]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[12]  Y. Itoyama,et al.  Interferon beta-1b is effective in Japanese RRMS patients , 2005, Neurology.

[13]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[14]  J. Kira.  Multiple sclerosis in the Japanese population , 2003, The Lancet Neurology.

[15]  A. Matsumori,et al.  Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey , 2002, Heart.

[16]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[17]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[18]  Shozo Tobimatsu,et al.  Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders , 1996, Annals of neurology.

[19]  M. Charlton.  Multiple Sclerosis East and West , 1983 .

[20]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[21]  S. Takeda,et al.  Comparison of MS Pathology between 70 American and 75 Japanese Autopsy Cases , 1982 .

[22]  H. Shibasaki,et al.  Nationwide survey of multiple sclerosis in Japan Clinical analysis of 1,084 cases , 1975, Neurology.

[23]  F. Mcdowell,et al.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS , 1965, Annals of the New York Academy of Sciences.

[24]  H. Yanagawa,et al.  Response Bias in the Nationwide Epidemiological Survey of an Intractable Disease in Japan , 1991 .